V beta 17 T-cell receptor peptide vaccine. Results of a phase I dose-finding study in patients with rheumatoid arthritis

Ann N Y Acad Sci. 1995 Jul 7:756:211-4. doi: 10.1111/j.1749-6632.1995.tb44514.x.

Authors

L W Moreland¹, L W Heck Jr, W J Koopman, P A Saway, T C Adamson, Z Fronek, R D O'Connor, E E Morgan, J P Diveley, N M Chieffo, et al.

Affiliation

¹ University of Alabama at Birmingham 068 Spain Rehabilitation Center 35294-0006, USA.

PMID: 7645836
DOI: 10.1111/j.1749-6632.1995.tb44514.x

No abstract available

Publication types

Clinical Trial
Clinical Trial, Phase I

MeSH terms

Adult
Arthritis, Rheumatoid / therapy*
Dose-Response Relationship, Immunologic
Gene Rearrangement, beta-Chain T-Cell Antigen Receptor
Humans
Immunotherapy
Lymphocyte Activation
Peptides / immunology
Receptors, Antigen, T-Cell, alpha-beta / chemistry
Receptors, Antigen, T-Cell, alpha-beta / immunology*
T-Lymphocytes / immunology*
T-Lymphocytes / pathology
Vaccination

Substances

Peptides
Receptors, Antigen, T-Cell, alpha-beta